<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00799669</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000626365</org_study_id>
    <secondary_id>MDA-2005-0791</secondary_id>
    <secondary_id>CDR0000626365</secondary_id>
    <secondary_id>U54CA096300</secondary_id>
    <secondary_id>U54CA096297</secondary_id>
    <secondary_id>NCI-2012-02110</secondary_id>
    <nct_id>NCT00799669</nct_id>
  </id_info>
  <brief_title>Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use</brief_title>
  <official_title>Cancer Risk Reduction Through Combined Treatment for Tobacco and Alcohol Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: A counseling program that motivates patients to stop smoking and drinking may&#xD;
      reduce the risk of oral cancer. It is not yet known whether motivational stop smoking&#xD;
      counseling or motivational stop-smoking and stop drinking counseling is more effective in&#xD;
      helping patients stop smoking and drinking.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial is studying how well treatment to stop smoking and&#xD;
      drinking works in preventing oral cancer in smokers in Puerto Rico.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  To evaluate the effects of a motivational and problem-solving smoking cessation (MAPS)&#xD;
           and a motivational and problem solving approach on at-risk alcohol use and smoking&#xD;
           cessation (MAPS+) among Puerto Rican at-risk drinkers/smokers who call the Puerto Rico&#xD;
           Quitline (PRQ).&#xD;
&#xD;
        -  To assess effects of MAPS and MAPS+ on treatment mechanisms and the role of those&#xD;
           mechanisms in mediating these effects on at-risk drinking and smoking cessation.&#xD;
&#xD;
        -  To evaluate the cost-effectiveness of MAPS and MAPS+ in the reduction of at-risk&#xD;
           drinking and smoking cessation.&#xD;
&#xD;
      OUTLINE: Minimization randomization is applied using the following variables: age, gender,&#xD;
      cigarettes/day, number of drinks/day, and depression (score on the Center of Epidemiologic&#xD;
      Studies Depression Scale). Patients are randomized to 1 of 2 intervention arms.&#xD;
&#xD;
        -  Arm I (MAPS): Patients receive culturally sensitive self-help materials tailored for&#xD;
           alcohol and tobacco users and 7 telephone counseling calls. The MAPS approach includes&#xD;
           motivational interviewing and cognitive behavioral/problem-solving that focus on smoking&#xD;
           cessation.&#xD;
&#xD;
        -  Arm II (MAPS+): Patients receive culturally sensitive self-help materials tailored for&#xD;
           alcohol and tobacco users and 7 telephone counseling calls. The MAPS+ approach includes&#xD;
           motivational interviewing and cognitive behavioral/problems solving that focus on&#xD;
           smoking cessation and the reduction of at-risk alcohol use.&#xD;
&#xD;
      In both arms, patients receive counseling calls over 15-30 minutes the week before quit date&#xD;
      (QD), on QD, 3-5 days after QD, 7-10 days after QD, 15-30 days after QD, 45-60 days after QD,&#xD;
      and on day 90 after QD. Patients complete questionnaires for alcohol- and smoking-related&#xD;
      measures, self efficacy, stress/negative affects/depression, social support, and physical&#xD;
      activity at baseline and weeks 12, 26 and 52 after QD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date type="Actual">December 5, 2007</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Participant At-risk drinking status</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Smoking cessation</measure>
    <time_frame>52 weeks</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">370</enrollment>
  <condition>Head and Neck Cancer</condition>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>MAPS+</arm_group_label>
    <description>MAPS+ (Motivation and Problem-Solving Plus):&#xD;
Counseling using specific treatment approach that focuses on combined smoking cessation and the reduction of at-risk alcohol use.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MAPS</arm_group_label>
    <description>MAPS (Motivation and Problem-Solving):&#xD;
Counseling treatment approach with a focus on smoking cessation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>smoking cessation intervention</intervention_name>
    <description>Standard quit-smoking counseling to help decrease their risk of cancer.</description>
    <arm_group_label>MAPS</arm_group_label>
    <arm_group_label>MAPS+</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
    <description>Counseling focusing on decreasing risk of getting cancer by decreasing smoking and alcohol use.</description>
    <arm_group_label>MAPS+</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>preventive intervention</intervention_name>
    <arm_group_label>MAPS+</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <arm_group_label>MAPS</arm_group_label>
    <arm_group_label>MAPS+</arm_group_label>
    <other_name>survey</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult Smokers Residing in Puerto Rico&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Current daily smoker&#xD;
&#xD;
          -  Called the Puerto Rico Quitline&#xD;
&#xD;
          -  Motivated to quit smoking in the next 30 days&#xD;
&#xD;
          -  Exhibits at least one of the following criteria for at-risk drinking:&#xD;
&#xD;
               -  An average of ≥ 2 alcoholic beverages/day for men or ≥ 1 drink/day for women in&#xD;
                  the past 30 days&#xD;
&#xD;
               -  Two or more occasions of consuming ≥ 5 alcoholic beverages/day for men or ≥ 4&#xD;
                  drinks/day for women in the past 30 days&#xD;
&#xD;
               -  Driving after consuming ≥ 3 drinks in the past 30 days&#xD;
&#xD;
          -  Score of ≤ 15 on the Alcohol Use Disorders Identification Test&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  Not pregnant&#xD;
&#xD;
          -  Residing in Puerto Rico&#xD;
&#xD;
          -  Not currently incarcerated or in jail&#xD;
&#xD;
          -  No other household member enrolled in this study&#xD;
&#xD;
          -  Viable telephone number and home address&#xD;
&#xD;
          -  Willing to provide the names, addresses, and phone numbers of up to 3 collaterals&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Wetter, PhD, MS, BA</last_name>
    <role>Study Chair</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Official Website</description>
  </link>
  <link>
    <url>http://www.cancer.gov/about-cancer/treatment/clinical-trials/search?</url>
    <description>National Cancer Institute (NCI) Central Website for Cancer Research</description>
  </link>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 27, 2008</study_first_submitted>
  <study_first_submitted_qc>November 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2008</study_first_posted>
  <last_update_submitted>November 7, 2018</last_update_submitted>
  <last_update_submitted_qc>November 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hypopharyngeal cancer</keyword>
  <keyword>laryngeal cancer</keyword>
  <keyword>lip and oral cavity cancer</keyword>
  <keyword>nasopharyngeal cancer</keyword>
  <keyword>oropharyngeal cancer</keyword>
  <keyword>paranasal sinus and nasal cavity cancer</keyword>
  <keyword>tobacco use disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

